Being the only component with enzyme activity, CSN5 is critical in regulating SCF-mediated protein degradation [20, 26]; therefore, we hypothesize that CSN5 overexpression may influence the therapeutical effects of MLN4924 in cervical cancer. Here, COPS5 is linked to cervical carcinoma.